Stock listing

Altimmune, Inc.

Selected listing: ALT · NASDAQ · USD · US

Altimmune, Inc. (NASDAQ:ALT), Health Technology. Latest release Sep 23, 2026: Altimmune to Participate in Stifel Cardiometabolic Forum.

ALT:NASDAQUSDUSUpdated October 2, 2026

Ticker: NASDAQ:ALT
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: NASDAQ
Currency: USD

About Altimmune, Inc.

Altimmune, Inc. is a public company traded under the ticker ALT in the American market. Altimmune focuses on developing innovative therapies to address unmet medical needs.

Latest news from Altimmune, Inc.

Altimmune to Participate in Stifel Cardiometabolic Forum

September 23, 2026

Altimmune to Participate in the Wells Fargo 21st Annual Healthcare Conference

September 3, 2026

Altimmune Announces Second Quarter 2026 Financial Results and Business Update

August 12, 2026

Altimmune to Report Second Quarter 2026 Financial Results and Provide Business Update on August 12, 2026

August 5, 2026

Altimmune Initiates PERFORMA Phase 3 Trial of Pemvidutide in Patients with MASH

August 3, 2026

All Altimmune, Inc. news →

Events

Replays

Altimmune, Inc. (ALT) Q2 2026 Earnings Call
Wed, Aug 12, 2026 · 08:30 AM ET
Watch
Altimmune, Inc. (ALT) Q1 2026 Earnings Call
Wed, May 13, 2026 · 08:30 AM ET
Watch
Altimmune, Inc. (ALT) Q4 2025 Earnings Call
Thu, Mar 05, 2026 · 08:30 AM ET
Watch

Research Altimmune, Inc.

Altimmune, Inc. company profile

View the public company page for Altimmune, Inc. on 6ix.

Altimmune, Inc. news

Read company news and market updates connected to Altimmune, Inc..

Altimmune, Inc. investor events

Find investor webinars, events, and replay context for Altimmune, Inc..